Corcept Therapeutics Incorporated
Organization details
- Legal name
- Corcept Therapeutics Incorporated
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Redwood City
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CORT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001088856
- EIN
- 77-0487658
- Wikidata ID
- Q15734041
Board of directors
-
Daniel N. Swisher Jr. · DirectorSince 2023
-
David L. Mahoney · DirectorSince 2023
-
G. Leonard Baker Jr. · DirectorSince 2023
-
Gillian Cannon · DirectorSince 2023
-
Gregg H. Alton · DirectorSince 2023
-
James N. Wilson · DirectorSince 2023
-
Joseph K. Belanoff · Director · Chief Executive OfficerSince 2023
-
Joshua M. Murray · DirectorSince 2023
-
Kimberly Park · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
66.1%
-
84.0%
-
87.5%
-
88.0%
-
90.9%
-
94.1%
-
99.3%
-
99.6%
Board connections
4 of this board's directors also sit on 6 other boards. 5 are in the same sector.
- via Joshua M. Murray
-
Cerus Corporation Same sectorvia Daniel N. Swisher Jr.
-
Lunai Bioworks Inc. Same sectorvia Gregg H. Alton
-
Novavax Inc. Same sectorvia Gregg H. Alton
-
Protagonist Therapeutics Inc. Same sectorvia Daniel N. Swisher Jr.
-
Xenon Pharmaceuticals Inc. Same sectorvia Gillian Cannon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $3,313,562
- 2 purchases by 1 insider
- Sold, last 12 months
- $97,564,469
- 106 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Maduck Sean See Remarks | Option exercise | +13,159 | $8.27 | $108,825 |
| Nov 3, 2026 | Maduck Sean See Remarks | Open-market sale | −8,617 | $82.02 | $706,765 |
| Nov 3, 2026 | Maduck Sean See Remarks | Open-market sale | −4,542 | $82.68 | $375,513 |
| Nov 2, 2026 | Vieira Roberto Wandenkolk Officer (President, Oncology) | Option exercise | +8,333 | $21.63 | $180,243 |
| Nov 2, 2026 | Maduck Sean See Remarks | Option exercise | +11,841 | $8.27 | $97,925 |
| Nov 2, 2026 | Vieira Roberto Wandenkolk Officer (President, Oncology) | Open-market sale | −6,657 | $80.73 | $537,437 |
| Nov 2, 2026 | Maduck Sean See Remarks | Open-market sale | −11,841 | $81.42 | $964,074 |
| Nov 2, 2026 | Vieira Roberto Wandenkolk Officer (President, Oncology) | Open-market sale | −1,676 | $81.52 | $136,632 |
| Oct 15, 2026 | James N. Wilson Director | Open-market sale | −6,654 | $114.48 | $761,717 |
| Oct 15, 2026 | James N. Wilson Director | Open-market sale | −3,046 | $115.39 | $351,476 |
| Oct 15, 2026 | James N. Wilson Director | Open-market sale | −300 | $116.30 | $34,889 |
| Oct 2, 2026 | Vieira Roberto Wandenkolk Officer (President, Oncology) | Option exercise | +8,333 | $21.63 | $180,243 |
| Oct 2, 2026 | Vieira Roberto Wandenkolk Officer (President, Oncology) | Open-market sale | −1,100 | $114.52 | $125,973 |
| Oct 2, 2026 | Maduck Sean Officer (See Remarks) | Option exercise | +24,587 | $8.27 | $203,334 |
| Oct 2, 2026 | Lyon Joseph Douglas Officer (See Remarks) | Option exercise | +3,357 | $13.56 | $45,521 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Corcept Therapeutics Incorporated
Who is the CEO of Corcept Therapeutics Incorporated?
Joseph K. Belanoff is Corcept Therapeutics Incorporated's Chief Executive Officer.
How many directors are on Corcept Therapeutics Incorporated's board?
Corcept Therapeutics Incorporated's board has 9 directors: Daniel N. Swisher Jr., David L. Mahoney, G. Leonard Baker Jr., Gillian Cannon, Gregg H. Alton, James N. Wilson, Joseph K. Belanoff, Joshua M. Murray and Kimberly Park.
Are Corcept Therapeutics Incorporated insiders buying or selling shares?
Over the last 12 months, Corcept Therapeutics Incorporated insiders bought $3.3 million of shares in 2 purchases and sold $97.6 million of shares in 106 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="corcept-therapeutics-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.